Skip to main content

Table 1 Factors associated with delayed ART/antiretroviral prophylaxis initiation among women diagnosed with HIV during their current pregnancy

From: Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar: A cross sectional study

Descriptiontotalcol %delay¥row %PR (95% CI)aPR(95% CI)
Total180 10961%  
age group
  < =2095%556%1 
 21–3011262%6659%1.1 (0.6–1.9) 
  > =315933%3864%1.2 (0.6–2.1) 
township
 Township 1116%218%11
 Township 26335%3759%3.2 (0.9–11.5)3.6 (0.8–15.5)
 Township 3169%638%2.1 (0.5–8.4)2.4 (0.5–11.8)
 Township 45832%4374%4.1 (1.1–14.5)*4.2 (1.2–14.8)*
 Township 53218%2166%3.6 (1.0–13.0)3.6 (1.0–13.0)
CD4 count
  < 35010056%6464%1.1 (0.9–1.5) 
  ≥ 3507341%4156%1 
 Missing74%457%  
WHO staging
 Stage I/II15486%9159%1 
 Stage III/IV158%1173%1.2 (0.9–1.7) 
 Missing116%764%  
Occupation
 Yes6335%3860%1 
 No8748%5361%1 (0.8–1.3) 
 Missing3017%1860%  
Distance
  ≤6 km6938%3652%11
  > 6 km10056%6666%1.3 (1–1.7)1.2 (0.5–2.5)
 Missing116%764%  
  1. ART/antiretroviral prophylaxis Antiretroviral therapy/Antiretroviral prophylaxis, col% column percentage, PR prevalence ratio, 95% CI 95% confidence interval, aPR adjusted prevalence ratio, ¥ delay initiation of ART/antiretroviral prophylaxis, km kilometer, *p value< 0.05, p-value < 0.2 were included in adjusted analysis, Delayed intiation of ART/antiretroviral prophylaxis = more than 2 week from date of HIV dagnosis.